Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls
Completed
- Conditions
- Prader-Willi Syndrome
- Registration Number
- NCT00932932
- Lead Sponsor
- Children's Mercy Hospital Kansas City
- Brief Summary
The purpose of the study is to find out if people with Prader-Willi syndrome have a difference in the protein which changes inactive cortisone to the active stress hormone cortisol.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
- Prader-Willi syndrome confirmed by molecular testing, ages 6 months to adult
- Controls: Age-matched, sex-matched, developmentally normal, BMI-controlled healthy or obese subjects
Exclusion Criteria
- PWS subjects without molecular confirmation of the diagnosis
- Subjects receiving glucocorticoid treatment within 3 months of evaluation
- Subjects receiving growth hormone within one year prior to analysis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method